Bryant J - Search Results

1

Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.

Whiteside TL, Bryant J, Day R, Herberman RB. Whiteside TL, et al. Among authors: bryant j. J Clin Lab Anal. 1990;4(2):102-14. doi: 10.1002/jcla.1860040207. J Clin Lab Anal. 1990. PMID: 2179501 Review.

2

Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant.

Jain AB, Todo S, Fung JJ, Venkataramanan R, Day R, Bryant J, Abu-Elmagd KM, Alessiani M, Takaya S, Tzakis A, et al. Jain AB, et al. Among authors: bryant j. Transplant Proc. 1991 Dec;23(6):3023-5. Transplant Proc. 1991. PMID: 1721347 Free PMC article. Clinical Trial. No abstract available.

3

Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506.

Whiteside TL, Wilson J, Bryant J, Zeevi A, Abu el-Magd K, Jain A, Alessiani M, Fung J, Herberman RB, Starzl TE. Whiteside TL, et al. Among authors: bryant j. Transplant Proc. 1991 Dec;23(6):3047-51. Transplant Proc. 1991. PMID: 1721356 Free PMC article. Clinical Trial. No abstract available.

4

Calculation of lytic units for the expression of cell-mediated cytotoxicity.

Bryant J, Day R, Whiteside TL, Herberman RB. Bryant J, et al. J Immunol Methods. 1992 Jan 21;146(1):91-103. doi: 10.1016/0022-1759(92)90052-u. J Immunol Methods. 1992. PMID: 1735786

5

Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution.

Furukawa H, Todo S, Imventarza O, Casavilla A, Wu YM, Scotti-Foglieni C, Broznick B, Bryant J, Day R, Starzl TE. Furukawa H, et al. Among authors: bryant j. Transplantation. 1991 May;51(5):1000-4. doi: 10.1097/00007890-199105000-00013. Transplantation. 1991. PMID: 2031256 Free PMC article.

6

In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation.

Friberg D, Bryant J, Shannon W, Whiteside TL. Friberg D, et al. Among authors: bryant j. Clin Diagn Lab Immunol. 1994 May;1(3):261-8. doi: 10.1128/cdli.1.3.261-268.1994. Clin Diagn Lab Immunol. 1994. PMID: 7496960 Free PMC article. Clinical Trial.

7

Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.

Appasamy R, Bryant J, Hassanein T, Van Thiel DH, Whiteside TL. Appasamy R, et al. Among authors: bryant j. Clin Immunol Immunopathol. 1994 Dec;73(3):350-7. doi: 10.1006/clin.1994.1209. Clin Immunol Immunopathol. 1994. PMID: 7955564 Clinical Trial.

8

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.

Whiteside TL, Letessier E, Hirabayashi H, Vitolo D, Bryant J, Barnes L, Snyderman C, Johnson JT, Myers E, Herberman RB, et al. Whiteside TL, et al. Among authors: bryant j. Cancer Res. 1993 Dec 1;53(23):5654-62. Cancer Res. 1993. PMID: 8242620

9

An application of decision theory to patient screening for an autologous tumour vaccine trial.

Shannon WD, Bryant J, Logan TF, Day R. Shannon WD, et al. Among authors: bryant j. Stat Med. 1995 Oct 15;14(19):2099-110. doi: 10.1002/sim.4780141904. Stat Med. 1995. PMID: 8552889

10

Incorporating toxicity considerations into the design of two-stage phase II clinical trials.

Bryant J, Day R. Bryant J, et al. Biometrics. 1995 Dec;51(4):1372-83. Biometrics. 1995. PMID: 8589229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,842 results

Search Page

Filters